SEC Form 4 · accession 0001493152-26-042169
Hepion Pharmaceuticals, Inc. · HEPA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Purcell
Director
Period of report
Aug 19, 2026
Accepted (ET)
Sep 10, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001583771
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $0.08 | Aug 19, 2026 | A | 299,000 | A | Aug 19, 2027 | Aug 19, 2036 | Common Stock | 299,000 | 299,000 | D |